Recent Articles from Business Wire

BostonGene to Present Multimodal AI Advances in Tumor-of-Origin Classification and Tumor Microenvironment Profiling at the ESMO AI & Digital Oncology Congress 2026
BostonGene, developer of an AI model for tumor and immune biology, today announced its participation in ESMO AI & Digital Oncology Congress 2026 taking place November 16–18, 2026 in Berlin, Germany. The international forum unites oncologists, data scientists, and industry leaders to showcase advances in AI and computational biology across cancer care.
By BostonGene Corporation · Via Business Wire · November 16, 2026
TRIMTECH Therapeutics Enters Strategic Research Collaboration With Biogen to Advance Small Molecule Degraders for Neurodegenerative Disease
TRIMTECH Therapeutics, a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has entered into a strategic research collaboration, option, and license agreement with Biogen International GmbH.
By TRIMTECH Therapeutics · Via Business Wire · November 16, 2026
858 Therapeutics Appoints Dr. Srini Ramanathan as Chief Executive Officer to Lead Next Phase of Company Growth
858 Therapeutics, a biotechnology company focused on developing novel oncology therapeutics, today announced the appointment of Srini Ramanathan, Ph.D., as Chief Executive Officer. Dr. Ramanathan brings extensive drug development and clinical execution experience as the company advances its PARG inhibitor ETX-19477 in clinical trials. Dr. Jeffrey Stafford, founding CEO of 858 Therapeutics, will transition to the role of Executive Chairman of the Board of Directors.
By 858 Therapeutics · Via Business Wire · November 16, 2026
Seawolf Therapeutics Debuts With $100 Million to Advance DNA-Based Therapeutics
Seawolf Therapeutics (“Seawolf”) today announced its emergence from stealth, having raised $100 million to transform patient outcomes through the use of its proprietary DNA delivery platform.
By Seawolf Therapeutics · Via Business Wire · November 16, 2026
Nidec Announces Approval of an Extension of the Filing Deadline of Semi-Annual Securities Report for the 54th Fiscal Year (Ending March 31, 2027)
As announced in " Notice Regarding Filing of an Application for Approval of an Extension of the Filing Deadline of Semi-Annual Securities Report for the 54th Fiscal Year (Ending March 31, 2027)" dated November 16, 2026, Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the "Company") had filed an application for approval of an extension of the filing deadline of Semi-Annual Securities Report for the 54th Fiscal Year (Ending March 31, 2027) prescribed in Article 18-2, Paragraph (1) of the Cabinet Office Ordinance on Disclosure of Corporate Affairs.
By NIDEC CORPORATION · Via Business Wire · November 16, 2026
Laverock Therapeutics Appoints Parker Moss as Chief Executive Officer and Paul J. Sekhri as Executive Chairman
Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through its programmable gene control technology, today announced the appointment of Parker Moss as Chief Executive Officer and member of the Board of Directors, and Paul J. Sekhri as Executive Chairman. Together they will lead Laverock through its transition into a clinical-stage company, including a Series A financing planned for 2027.
By Laverock Therapeutics · Via Business Wire · November 16, 2026
Houlihan Lokey Further Expands Global Oil & Gas Group With Senior Hire in London
Houlihan Lokey, Inc. (NYSE:HLI), the global investment bank, today announced the appointment of Fahd Aijaz as a Managing Director in the Oil & Gas Group. Based in London, Mr. Aijaz will lead the firm’s industry coverage of European companies and investors, in collaboration with other senior partners across the global Oil & Gas Group.
By Houlihan Lokey, Inc. · Via Business Wire · November 16, 2026
LEO Pharma Delivers 11% Revenue Growth at CER and Achieves Strategic Milestones
In 9M 2026, LEO Pharma delivered strong innovation-led growth, with a significantly improved gross margin and continued investment in innovation. In September, LEO Pharma completed the acquisition of dersimelagon, an investigational first-in-class oral therapy now under FDA Priority Review, marking an important strategic milestone. Momentum continued after the period, with new approvals for Anzupgo® in Europe and China, further extending the product’s reach and underscoring LEO Pharma’s commitment to advancing innovation in dermatology.
By LEO Pharma · Via Business Wire · November 16, 2026
Syntis Bio Reports Late-Breaking SYNTIETY-1 Data at ObesityWeek® 2026 Demonstrating Daily Oral SYNT-101 Mimics Gastric Bypass Hormone Response with Placebo-Like Tolerability
Syntis Bio, Inc., a clinical-stage biopharmaceutical company advancing novel oral therapeutics that uniquely leverage the small intestine, today announced that results from its Phase 1/1b SYNTIETY-1 trial of SYNT-101, an investigational once-daily tablet for obesity, in two posters, including a late-breaking presentation, were presented at The Obesity Society’s 44th Annual Meeting at ObesityWeek® 2026. Data from the trial demonstrated that SYNT-101 reproduced the meal-driven gut-hormone response of gastric bypass surgery, produced placebo-adjusted weight loss over 28 days, and was well tolerated, with gastrointestinal (GI) adverse events comparable to placebo and no discontinuations.
By Syntis Bio · Via Business Wire · November 16, 2026
ViiV Healthcare’s Tivicay and Dovato receive positive CHMP opinion for young children living with HIV, advancing efforts to close paediatric treatment gaps in the EU
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of Tivicay (dolutegravir [DTG]) and Dovato (dolutegravir/lamivudine [DTG/3TC]) to extend their use to eligible younger age groups.
By ViiV Healthcare · Via Business Wire · November 16, 2026
Plural Raises €1bn to Back the Frontier Founders Building a New Europe
Plural, the early-stage investment fund led by founders and operators, has raised €1bn to back the founders Europe is counting on.
By Plural · Via Business Wire · November 16, 2026
Nidec Announces Disclosure of the Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2027, Exceeding 45 Days After the Quarter-End
Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) hereby announces that the scheduled disclosure date of the financial results for the second quarter of the fiscal year ending March 31, 2027, will exceed 45 days after the quarter-end, as detailed below.We sincerely apologize for any inconvenience and concern caused to our shareholders, investors, and other stakeholders.
By Nidec Corporation · Via Business Wire · November 16, 2026
SES and ITU Expand Partner2Connect Digital-learning Initiative to 30 African Schools
SES, a leading space solutions company, announced progress on its commitment to the International Telecommunication Union's (ITU) Partner2Connect Digital Coalition, through which the company is connecting 30 schools across Malawi, Burundi, Zambia, and Zimbabwe by the end of 2026. The initiative, developed in cooperation with the ITU Telecommunication Development Bureau, aims to expand access to digital education and online resources for an estimated 20,000 to 30,000 students and teachers in underserved and remote communities.
By SES · Via Business Wire · November 16, 2026
Regnology and ActiveViam Partner to Bring the Same Granular, Explainable Risk Intelligence to Banks and Their Supervisors
Regnology, a leading global technology provider at the intersection of regulatory reporting, risk management, finance, and supervisory technology, today announced a strategic partnership with ActiveViam, the provider of Atoti, the AI-native enterprise risk intelligence platform for capital markets. The partnership embeds Atoti as the real-time risk aggregation and analytics engine in Regnology Risk Hub, and will extend it to supervisory authorities through Regnology Supervisory Hub. Regnology is the only provider whose offering serves both the regulated and their regulators, with more than 15,000 financial institutions and more than 100 authorities as clients.
By Regnology · Via Business Wire · November 16, 2026
FreeCast Introduces True Voice AI: One Search Across the World of Entertainment
FreeCast, Inc. (NASDAQ: CAST), a provider of white-label streaming entertainment technology, today introduced True Voice AI, an intelligent entertainment assistant to be built into the FreeCast Watch App in coming days. Testing currently live on FreeCast's web interface, the new conversational interface will help viewers discover movies, television series, sports and related entertainment information by describing what they want, even when they remember only part of a title, an actor, a scene or a storyline.
By FreeCast, Inc. · Via Business Wire · November 16, 2026
QurAlis Receives FDA Clearance for IND Application of QRL-201 for the Treatment of ALS, Clearing a Path to Initiation of Pivotal Clinical Trial in the U.S.
QurAlis Corporation (“QurAlis”), today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for QRL-201 for the treatment of amyotrophic lateral sclerosis (ALS). The clearance enables QurAlis to advance the planned pivotal CONQUR clinical trial in the U.S.
By QurAlis Corporation · Via Business Wire · November 16, 2026
Omdia: Southeast Asia Smartphone Shipments Fall 36% in 3Q26 as Memory Supply Constraints Intensify
According to the latest research from Omdia, Southeast Asia's smartphone market declined 36% year-on-year (YoY) in 3Q26, with shipments falling to 16.5 million units. This contraction continues a trend seen in the first half of 2026, as memory supply shortages and rising component costs constrained vendor shipments.
By Omdia · Via Business Wire · November 16, 2026
Rio Tinto, BCL and ABG to establish fund to support Panguna mine legacy impact response
Rio Tinto, Bougainville Copper Limited (BCL) and the Autonomous Bougainville Government (ABG) have agreed with community leaders to establish a fund to support responses to impacts identified through the Panguna Mine Legacy Impact Assessment (PMLIA).
By Rio Tinto · Via Business Wire · November 16, 2026
Sofinnova Partners Closes €725M Crossover II Fund
Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final close of Sofinnova Crossover II at €725 million ($815 million USD).
By Sofinnova Partners · Via Business Wire · November 16, 2026
SkyDrive Wins Best Paper Award at VFS Heli Japan 2026
SkyDrive Inc. (“SkyDrive”), a leading compact eVTOL aircraft (*1) developer based in Japan, announced that a technical paper presented by its Aeronautics Development Department won the prestigious Best Paper Award at the 12th Asian / Australian Rotorcraft Forum / Heli Japan 2026, held in Gifu, Japan, and organized by the Vertical Flight Society (VFS), the world’s leading technical community dedicated to vertical flight.
By SkyDrive Inc. · Via Business Wire · November 16, 2026
Genentech’s Gazyva Becomes the First FDA-Approved Treatment for Primary Membranous Nephropathy
Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab) for the treatment of adult patients with primary membranous nephropathy (pMN) at risk of disease progression, to induce remission of proteinuria. Gazyva becomes the first and only therapy to receive FDA approval for this disease, having previously been granted Breakthrough Therapy Designation. A chronic autoimmune disease that can lead to kidney failure, pMN carries a substantial human and economic burden for patients, caregivers and health systems alike. Proteinuria is a key indicator of kidney damage characterized by high urine protein levels.
By Genentech · Via Business Wire · November 16, 2026
Finite State to Reveal Results of Six-Month, AI-Driven Firmware Security Research at Hardwear.io 2026
Finite State, a leader in product security and software supply chain risk management, today announced that Roland Lindsey, Chief Product Security Engineer, will present findings from six months of intensive firmware security research at Hardwear.io Netherlands 2026, taking place November 19–20 at the Amsterdam Marriott Hotel.
By Finite State · Via Business Wire · November 16, 2026
Xsolla Opens the Xsolla Clubhouse, an Industry Networking Lounge in Busan During G-STAR 2026
Xsolla (USA), Inc., a global commerce company that helps developers launch, grow, and monetize their games, will run the Xsolla Clubhouse in the 5th floor ballroom of the Grand Josun Busan on November 19 and 20, during G-STAR 2026.
By Xsolla · Via Business Wire · November 15, 2026
CAT Investors Have Opportunity to Join Caterpillar Inc. Fraud Investigation with SBS Law
Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Caterpillar Inc. (“Caterpillar” or “the Company”) (NYSE: CAT) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
Ant International’s Alipay+ and The New York Liberty Celebrate Season of Sustainability Impact on Community, Environmental and Youth Empowerment
Ant International’s Alipay+, a leading cross-border fintech services platform, and the WNBA’s New York Liberty, today announced the results of their joint sustainability initiatives for the season. Marking the first season of the multi-year collaboration, Alipay+ and the New York Liberty planted a total of 219 trees — one for every three-pointer made by the New York Liberty and Alipay+ in-game fan contestants during home games at Barclays Center this season.
By Alipay+ · Via Business Wire · November 15, 2026
LWLG Investors Have Opportunity to Join Lightwave Logic, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Lightwave Logic, Inc. (“Lightwave” or “the Company”) (NASDAQ: LWLG) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
TNET Investors Have Opportunity to Join TriNet Group, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TriNet Group, Inc. (“TriNet” or “the Company”) (NYSE: TNET) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Life Insurance Segment
AM Best is maintaining its stable outlook on New Zealand’s life insurance segment, as the nation’s life insurers continue to deliver solid profitability despite challenging market and macroeconomic conditions.
By AM Best · Via Business Wire · November 15, 2026
GSHD Investors Have Opportunity to Join Goosehead Insurance, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Goosehead Insurance, Inc. (“Goosehead” or “the Company”) (NASDAQ: GSHD) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
PT Freeport Indonesia Announces Senior Notes Offering
PT Freeport Indonesia (“PTFI” or the “Company”) announced today that it intends to offer one or more series of U.S. Dollar denominated senior notes (the “Notes”), subject to market and other conditions (the “Notes Offering”). PTFI intends to use the net proceeds from the Notes Offering to refinance existing indebtedness and for general corporate purposes. The Notes are expected to be rated “Baa3” by Moody’s and “BBB” by Fitch.
By Freeport-McMoRan Inc. · Via Business Wire · November 15, 2026
Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
AM Best is maintaining a stable outlook on the New Zealand non-life insurance segment, citing in part ongoing regulatory reforms that are expected to strengthen market discipline and governance over the long term.
By A.M. Best Rating Services, Inc. · Via Business Wire · November 15, 2026
MNTK Investors Have Opportunity to Join Montauk Renewables, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
Faraday Future Founder and Global CEO YT Jia Shares Weekly Updates on Robots Delivery to Central Michigan University, Brain Blocks AI Module, and Industrial Scenario Validation
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business update from YT Jia, Founder and Global CEO of FF and FFR.
XRX Investors Have Opportunity to Join Xerox Holdings Corporation Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Xerox Holdings Corporation (“Xerox” or “the Company”) (NASDAQ: XRX) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
SW Investors Have Opportunity to Join Smurfit Westrock Plc Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Smurfit Westrock Plc (“Smurfit Westrock” or “the Company”) (NYSE: SW) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
Palliser Capital Calls on LG Chem to Accelerate Value Enhancement Efforts and Strengthen Board Ahead of 2027 AGM
Palliser Capital ("Palliser"), one of the largest independent shareholders of LG Chem, Ltd. ("LG Chem" or the "Company"), today published a letter to the Company's Board of Directors welcoming its recent share buyback announcement, while calling for more ambitious and sustained action to address its persistent discount to net asset value ("NAV"), strengthen corporate governance and unlock long-term shareholder value.
By Palliser Capital · Via Business Wire · November 15, 2026
GILT Investors Have Opportunity to Join Gilat Satellite Networks Ltd. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Gilat Satellite Networks Ltd. (“Gilat” or “the Company”) (NASDAQ: GILT) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
IHRT Investors Have Opportunity to Join iHeartMedia, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of iHeartMedia, Inc. (“iHeartMedia” or “the Company”) (NASDAQ: IHRT) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 15, 2026
Investor Alert: Robbins LLP Informs Investors of the Intel Corporation Class Action Lawsuit
Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all purchasers of Intel Corporation (NASDAQ: INTC) common stock between July 23, 2026 and October 29, 2026, inclusive (the “Class Period”). Intel is a global designer and manufacturer of semiconductor and other computer component products, such as central processing units ("CPUs") and other microprocessors.
By Robbins LLP · Via Business Wire · November 15, 2026
Summit Therapeutics Provides Update Regarding Ivonescimab Biologics License Application
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for ivonescimab in combination with platinum-containing chemotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), who have received prior epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy. Ivonescimab is a novel PD-1 x VEGF bispecific antibody.
By Summit Therapeutics · Via Business Wire · November 15, 2026
GoGoMeds Appoints Harish Panchal as Chief Executive Officer
GoGoMeds, a technology-enabled pharmacy specializing in prescription fulfillment, compounded medications, and direct-to-patient delivery, today announced the appointment of Harish Panchal as Chief Executive Officer. Panchal succeeds Cole Maudlin, whose leadership helped guide GoGoMeds through a period of significant growth and expanded capabilities.
By GoGoMeds · Via Business Wire · November 15, 2026
Luvme Announces Black Friday Early Access: $140 Off + Price Protection
Luvme Hair is introducing its next Black Friday Early Access promotion, offering customers savings of up to $140 off qualifying orders alongside a new price protection initiative. Running from November 17 through November 26, 2026, the promotion features two shopping events designed to provide greater value and more confidence when shopping early.
By Luvme Hair · Via Business Wire · November 15, 2026
BA Investors Who Received Shares of The Boeing Company in Connection to Its Merger with Spirit AeroSystems Can Join Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Boeing Company (“Boeing” or “the Company”) (NYSE: BA) who received shares in connection with its December 2025 merger (“the Merger”) with Spirit AeroSystems Holdings, Inc. (“Spirit”) (NYSE: SPR) for violations of the securities laws.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 14, 2026
INTC Investors Have Opportunity to Lead Intel Corporation Securities Fraud Lawsuit with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intel Corporation (“Intel” or “the Company”) (NASDAQ: INTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By Schall, Brown & Schwartz LLP · Via Business Wire · November 14, 2026
Advanced eClinical Training Approved for New Jersey's Eligible Training Provider List
Advanced eClinical Training (ACT), a provider of accelerated, online allied health certification training, announces its approval for inclusion on New Jersey's Eligible Training Provider List (ETPL), administered by the New Jersey Department of Labor and Workforce Development (NJDOL).
By Advanced eClinical Training · Via Business Wire · November 14, 2026
Hot Wheels Crowns 2026 Legends Tour Winner Following Global Search Across 19 Countries
Mattel, Inc. (NASDAQ: MAT), a leading global play and family entertainment company and owner of one of the world’s most iconic brand portfolios, today announced the 2026 winner of the Hot Wheels™ Legends Tour presented by Mobil 1, the world’s largest traveling car show and global custom car competition. At the November 14 Global Grand Finale, Matt McEntegart’s custom 1979 Chevrolet El Camino, which began its journey by winning the Tampa stop, was crowned the global champion. The victory marks the first time a U.S. entry has won the global title since 2022. The one-of-a-kind creation will now be inducted into the Hot Wheels Garage of Legends™ and transformed by the Hot Wheels® design team into an official 1:64-scale die-cast collectible sold worldwide.
By Mattel · Via Business Wire · November 14, 2026
VedaBio Demonstrates Under-10-Minute Molecular Detection with Target Amplification-Free CRISPR Technology at AMP 2026
VedaBio, a pioneering biotechnology company transforming molecular detection, today announced new proof-of-concept data demonstrating sample-to-answer times of under 10 minutes using its integrated, target amplification-free CRISPR-based molecular diagnostics technology. The findings, presented at the Association for Molecular Pathology (AMP) 2026 Annual Meeting & Expo in Seattle, Washington, highlight the potential of the technology to help overcome longstanding challenges associated with bringing molecular testing closer to patients.
By VedaBio · Via Business Wire · November 14, 2026
Amylyx Pharmaceuticals Presents Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) will present the results from the 16-week double-blind treatment period of the Phase 3 LUCIDITY clinical trial of avexitide, an investigational, first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist, in participants with post-bariatric hypoglycemia (PBH) following Roux-en-Y gastric bypass (RYGB) surgery, in a late-breaking oral presentation on November 15th at the ObesityWeek® 2026 Annual Meeting.
By Amylyx Pharmaceuticals, Inc. · Via Business Wire · November 14, 2026
Zai Lab Announces First-Time Inclusion of KarXT and VYVGART Hytrulo® in China’s 2026 National Reimbursement Drug List, Expanding Access to Key Growth Products
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country’s 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings, expanding patient access to treatments for gMG and schizophrenia, and three renewals, which maintain access across oncology and infectious disease.
By Zai Lab Limited · Via Business Wire · November 13, 2026
Perioperative IMFINZI® (durvalumab) approved in the US in novel regimen with neoadjuvant enfortumab vedotin-ejfv for patients with muscle-invasive bladder cancer
AstraZeneca’s ​IMFINZI® (durvalumab)​ in combination with enfortumab vedotin-ejfv (EV) as neoadjuvant treatment, followed by IMFINZI monotherapy as adjuvant treatment after radical cystectomy (surgery to remove the bladder), has been approved in the US for the treatment of adult patients with muscle-invasive bladder cancer (MIBC) who are ineligible for or have refused cisplatin-based chemotherapy.
By AstraZeneca · Via Business Wire · November 13, 2026
Bloom Energy Supports Louisiana Disaster Relief Ahead of Texas-LSU Matchup
As Baton Rouge gets ready for the Texas-LSU matchup, Bloom Energy is joining the community off the field to support two organizations making a difference for families across Louisiana.
By Bloom Energy · Via Business Wire · November 13, 2026
Unified Women’s Healthcare Launches a New Initiative Aimed at Leveraging Routine OB/GYN Care to Identify Cardiovascular Risk Earlier and Connect More Women to Preventive Care
Unified Women’s Healthcare (Unified), one of the nation’s largest women’s healthcare organizations, is leading a new initiative to explore how routine OB/GYN care can play a greater role in identifying and addressing cardiovascular disease risk among women. Early support from the American Heart Association Go Red for Women Venture FundTM for a feasibility study by Unified’s Lucina Analytics subsidiary laid the groundwork for the initiative. Building on that foundation, Unified is leveraging Lucina’s AI-driven intelligence and embedded care management capabilities to help OB/GYN teams identify patients at elevated cardiovascular risk and connect them with care tailored to their risk level.
By Unified Women’s Healthcare · Via Business Wire · November 13, 2026
KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2026-CES11 (RCKT 2026-CES11)
KBRA assigns preliminary ratings to 20 classes of mortgage-backed notes from RCKT Mortgage Trust 2026-CES11 (RCKT 2026-CES11).
By Kroll Bond Rating Agency, LLC · Via Business Wire · November 13, 2026
DAS Technology Gives Retailers a Competitive Advantage During Microsoft Outage
DAS Technology, the technology company behind Digital Air Strike, announced today that its platforms and customer-facing communications, including but not limited to CDXPTM, AI Engage, Power Text and Smart Quote, have continued operating normally during the recent Microsoft outage, enabling automotive retail clients to maintain lead response and consumer engagement even when clients could not access their own Microsoft email systems.
By DAS Technology · Via Business Wire · November 13, 2026
Service Properties Trust Receives Statement of Support from Shareholder Flat Footed LLC
Service Properties Trust (Nasdaq: SVC) (“SVC” or the “Company”) today announced that Flat Footed LLC (“Flat Footed”), an SVC institutional shareholder, has expressed support for the plan announced earlier today by SVC’s Board of Trustees to transition SVC into a pure-play triple net lease REIT.
By Service Properties Trust · Via Business Wire · November 13, 2026
Organigram Provides NASDAQ Listing Update
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (the “Company” or “Organigram”), Canada's #1 cannabis company by market share¹ and a growing global cannabis platform, today announced that on November 11, 2026, it received notification (the “Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirement under Nasdaq Listing Rule 5450(a)(1) for continued listing on the Nasdaq Global Select Market. The Notification was issued because the closing bid price of the Company's common shares was below US$1.00 per share for 30 consecutive business days. Nasdaq Listing Rule 5450(a)(1) requires listed common shares to maintain a minimum bid price of US$1.00 per share (the “Minimum Bid Requirement”), while Nasdaq Listing Rule 5810(c)(3)(A) provides that a deficiency exists when the requirement is not met for 30 consecutive business days.
By Organigram Global Inc. · Via Business Wire · November 13, 2026
ADI GLOBAL DISTRIBUTION INC. INVESTIGATION: ADIG Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
The law firm of Kirby McInerney LLP is investigating potential claims against ADI Global Distribution Inc. (“ADI” or the “Company”) (NYSE: ADIG). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired ADI securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
By Kirby McInerney LLP · Via Business Wire · November 13, 2026
Trinity Place Holdings Inc. Reports Third Quarter Financial Results
Trinity Place Holdings Inc. (OTC PINK: TPHS) (the "Company," "we," "our," or "us") today announced operating results for the third quarter ended September 30, 2026.
By Trinity Place Holdings Inc. · Via Business Wire · November 13, 2026
PRIMORIS SERVICES CORPORATION INVESTIGATION: PRIM Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
The law firm of Kirby McInerney LLP is investigating potential claims against Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired Primoris securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
By Kirby McInerney LLP · Via Business Wire · November 13, 2026
LIGHTWAVE LOGIC, INC. INVESTIGATION: LWLG Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
The law firm of Kirby McInerney LLP is investigating potential claims against Lightwave Logic, Inc. (“Lightwave Logic” or the “Company”) (NASDAQ: LWLG). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired Lightwave Logic securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
By Kirby McInerney LLP · Via Business Wire · November 13, 2026
Sports Illustrated Resorts Opens in Nashville, Launching a National Sports Hospitality Brand
Travel + Leisure Co. (NYSE:TNL), a leading leisure travel and hospitality company, officially opens Sports Illustrated Resorts Nashville today, launching a national hospitality brand built around the games, teams and events fans love. The 185-suite resort on Music Row, one mile from downtown Nashville and the Gulch, is the first of four announced destinations totaling more than 800 suites and units.
By Travel + Leisure Co. · Via Business Wire · November 13, 2026
Datavault AI Receives Notice of Nasdaq Trading Suspension; Common Stock Eligible to Trade on OTC Markets
Datavault AI Inc. (“Datavault” or the “Company”) (OTC: DVLT), today announced that the Company expects its common stock will be eligible to trade on the over-the-counter market (“OTC Markets”) effective with the open of the market on November 17, 2026. The move to OTC Markets follows Nasdaq’s decision to suspend trading in the Company’s common stock effective November 17, 2026, due to the Company’s non-compliance with Nasdaq’s $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) and the “low stock price” rule set forth in Nasdaq Listing Rule 5810(c)(3)(A)(iii), which requires a suspension of Nasdaq trading for an issuer that evidences a closing bid price of less than $0.10 per share for ten consecutive business days.
By Datavault AI Inc. · Via Business Wire · November 13, 2026
KBRA Assigns Preliminary Ratings to PEAC Solutions Receivables 2026-2 LLC
KBRA assigns preliminary ratings to five classes of notes issued by PEAC Solutions Receivables 2026-2 (PEAC 2026-2), an equipment ABS transaction. PEAC 2026-2 will issue five classes of notes, including a short-term tranche. Credit enhancement includes excess spread, a reserve account, overcollateralization and subordination (except for Class C Notes). The overcollateralization is subject to a target equal to 18.10% of the current ASV and a floor equal to 1.00% of the initial ASV. The reserve account will be funded at 0.50% of the initial ASV and is non-amortizing.
By Kroll Bond Rating Agency, LLC · Via Business Wire · November 13, 2026
Service Properties Trust Receives Statement of Support from Shareholder Helix Partners Management LP
Service Properties Trust (Nasdaq: SVC) (“SVC” or the “Company”) today announced that Helix Partners Management LP (“Helix Partners”), SVC’s largest institutional shareholder, has issued a letter to SVC’s Board of Trustees (the “Board”) in support of the plan SVC’s Board has announced to transition SVC into a pure-play triple net lease REIT.
By Service Properties Trust · Via Business Wire · November 13, 2026
Seritage Growth Properties Reports Third Quarter 2026 Operating Results
Seritage Growth Properties (NYSE: SRG) (the “Company”), a national owner and developer of retail, residential and mixed-use properties today reported financial and operating results for the three and nine months ended September 30, 2026.
By Seritage Growth Properties · Via Business Wire · November 13, 2026
Eagle Capital Growth Fund Declares Year-End Distribution of $0.49 Per Share
The Eagle Capital Growth Fund, Inc. (“Fund”) (NYSE American: GRF) today declared a year-end distribution of $0.49 per share in cash. The record date for this distribution is November 27, 2026, and the payment date is December 17, 2026.
By Eagle Capital Growth Fund, Inc. · Via Business Wire · November 13, 2026
IRHYTHM HOLDINGS, INC. INVESTIGATION: IRTC Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights
The law firm of Kirby McInerney LLP is investigating potential claims against iRhythm Holdings, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired iRhythm securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.
By Kirby McInerney LLP · Via Business Wire · November 13, 2026
Xylem Inc. Announces $1.5 Billion Share Repurchase Authorization
Xylem Inc. (NYSE: XYL), a leading global water solutions company dedicated to solving the world’s most challenging water issues, today announced that its Board of Directors has authorized a new share repurchase program of its common stock of up to $1.5 billion, effective immediately. Repurchases may be made from time to time on the open market or in privately negotiated transactions. The Company intends to be opportunistic in its repurchases of stock based on market conditions and other factors, and may suspend or discontinue the repurchase program at any time.
By Xylem Inc. · Via Business Wire · November 13, 2026
AM Best Affirms Credit Ratings of Everest Group, Ltd and Its Subsidiaries
AM Best has affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term Issuer Credit Ratings (Long-Term ICR) of “aa-” (Superior) of the operating subsidiaries of Everest Group, Ltd. (Bermuda) (collectively referred to as Everest). Concurrently, AM Best has affirmed the Long-Term ICRs of “a-” (Excellent) of Everest Group, Ltd. and Everest Reinsurance Holdings, Inc. (Delaware). Lastly, AM Best has affirmed the Long-Term Issue Credit Rating (Long-Term IRs) of Everest Reinsurance Holdings, Inc. The outlook of these Credit Ratings (ratings) is negative. (See below for a detailed listing of the companies and Credit Ratings [ratings].)
By AM Best · Via Business Wire · November 13, 2026
Securities Fraud Lawsuit Filed Against Lennar Corporation: The Law Offices of Frank R. Cruz Outlines Lead Plaintiff Deadline
A securities class action lawsuit has been filed against Lennar Corporation ("Lennar" or the "Company") (NYSE: LEN) on behalf of investors who purchased or otherwise acquired Lennar Corporation securities from February 7, 2025 to October 2, 2026, inclusive. The Law Offices of Frank R. Cruz today reported the case, Triggs v. Lennar Corporation et al., filed on November 11, 2026 in the U.S. District Court Florida Southern District Court (Case No. 1:26-cv-28015). Lead plaintiff motions in the Lennar Corporation case are due by January 11, 2027.
By The Law Offices of Frank R. Cruz · Via Business Wire · November 13, 2026
Zai Lab Announces Participation in Investor Conferences in November 2026
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conferences in November 2026:
By Zai Lab Limited · Via Business Wire · November 13, 2026
Lost Money on Cardinal Infrastructure Group Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 62.37% Stock Decline
Cardinal Infrastructure Group Inc. ("Cardinal Infrastructure" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Cardinal Infrastructure Group Inc. (NASDAQ: CDNL), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Cardinal Infrastructure Group Inc. on November 12, 2026.
By The Law Offices of Frank R. Cruz · Via Business Wire · November 13, 2026
Syncora Guarantee Inc. Announces the Availability of Certain Financial Information
Syncora Guarantee Inc. (“Syncora Guarantee”) today announced that certain financial information of Syncora Guarantee has been made available on Syncora Guarantee's website (www.syncoraguarantee.com). The information posted is Syncora Guarantee’s Statutory Basis Financial Statements as of September 30, 2026 filed with the NAIC.
By Syncora Guarantee Inc. · Via Business Wire · November 13, 2026
Morgan Stanley Declares Dividends on Its Preferred Stock
Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues:
By Morgan Stanley · Via Business Wire · November 13, 2026
Siebert Reports Third Quarter 2026 Financial Results
Siebert Financial Corp. (NASDAQ: SIEB) (“Siebert”), a diversified provider of financial services, today reported financial results for the third quarter ended September 30, 2026.
By Siebert Financial Corp. · Via Business Wire · November 13, 2026